Particulars (Rupees in Crores.) | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Gross Sales | 390.81 | 368.65 | 390.21 | 361.2 | 329.36 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 390.81 | 368.65 | 390.21 | 361.2 | 329.36 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5.84 | 4.51 | 2.68 | 4 | 7.28 |
Total Income | 396.65 | 373.16 | 392.89 | 365.2 | 336.64 |
Total Expenditure | 356.62 | 333.87 | 348.26 | 333.64 | 307.11 |
PBIDT | 40.03 | 39.29 | 44.63 | 31.56 | 29.53 |
Interest | 14.95 | 14.29 | 16.38 | 12.44 | 12.58 |
PBDT | 25.08 | 25 | 28.25 | 19.12 | 16.95 |
Depreciation | 16.98 | 17.1 | 16.25 | 16.48 | 15.46 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 8.83 | 7.97 | 11.16 | 3.45 | 4.54 |
Deferred Tax | -7.21 | -6.41 | -8.22 | -2.08 | -13.73 |
Reported Profit After Tax | 6.48 | 6.34 | 9.06 | 1.27 | 10.68 |
Minority Interest After NP | 3.04 | 3.73 | 2.55 | 2.19 | 2.41 |
Net Profit after Minority Interest | 3.44 | 2.61 | 6.51 | -0.92 | 8.27 |
Extra-ordinary Items | 0.03 | 0.04 | 0 | -1.26 | -1.78 |
Adjusted Profit After Extra-ordinary item | 3.41 | 2.57 | 6.51 | 0.34 | 10.05 |
EPS (Unit Curr.) | 0.14 | 0.11 | 0.26 | -0.04 | 0.33 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 50.06 | 49.92 | 49.9 | 49.89 | 49.89 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 10.24 | 10.65 | 11.43 | 8.73 | 8.96 |
PBDTM(%) | 6.41 | 6.78 | 7.23 | 5.29 | 5.14 |
PATM(%) | 1.65 | 1.71 | 2.32 | 0.35 | 3.24 |
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.